Pediatrics. 2010 Apr;125(4):e906-18. Epub 2010 Mar 22.

Growth hormone: health considerations beyond height gain.

Ross J, Czernichow P, Biller BM, Colao A, Reiter E, Kiess W; advisory panel meeting on the effects of growth hormone.

Collaborators (6)

Christiansen JS, Haymond M, Hokken-Koelega A, Lee P, Ozono K, Shimatsu A.

Source

Department of Pediatrics, Thomas Jefferson University, 1025 Walnut St, Suite 726, Philadelphia, PA 19107, USA. judith.ross@jefferson.edu

Abstract

The therapeutic benefit of growth hormone (GH) therapy in improving height in short children is widely recognized; however, GH therapy is associated with other metabolic actions that may be of benefit in these children. Beneficial effects of GH on body composition have been documented in several different patient populations as well as improvements in lipid profile. Marked augmentation of bone mineral density also seems evident in many pediatric populations. Some of these benefits may require continued therapy past the acquisition of adult height. With long-term therapy of any kind, the adverse consequences of treatment should also be considered. Fortunately, long-term GH treatment seems to be safe and well-tolerated. This review describes the long-term metabolic effects of GH treatment in the pediatric population and considers how these may benefit children who are treated with GH.

PMID:: 20308212; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Human Growth Hormone

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. [Clin Endocrinol (Oxf). 2007]
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, et al. Clin Endocrinol (Oxf). 2007 Oct; 67(4):485-92. Epub 2007 Jun 11.
Review Growth hormone treatment for short stature in children born small for gestational age. [Adv Ther. 2008]
Review Growth hormone treatment for short stature in children born small for gestational age.
Jung H, Rosilio M, Blum WF, Drop SL. Adv Ther. 2008 Oct; 25(10):951-78.
Review Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone. [Curr Pharm Biotechnol. 2000]
Review Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
Lanes R. Curr Pharm Biotechnol. 2000 Jul; 1(1):33-46.
Review Long-term outcome of growth hormone therapy in children and adolescents. [Treat Endocrinol. 2004]
Review Long-term outcome of growth hormone therapy in children and adolescents.
Lanes R. Treat Endocrinol. 2004; 3(1):53-66.
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. [Bone. 2005]
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone. 2005 Nov; 37(5):642-50. Epub 2005 Sep 1.

See reviews... See all...

Cited by 1 PubMed Central article

Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. [Am J Gastroenterol. 2011]
Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.
Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Lahsinoui HH, Akkad A, Grand RJ, Gordon CM. Am J Gastroenterol. 2011 Aug; 106(8):1527-43. Epub 2011 Apr 26.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Growth hormone: health considerations beyond height gain.
Growth hormone: health considerations beyond height gain.
Pediatrics. 2010 Apr ;125(4):e906-18. Epub 2010 Mar 22 .

PubMed
The RNF8/RNF168 ubiquitin ligase cascade facilitates class switch recombination.
The RNF8/RNF168 ubiquitin ligase cascade facilitates class switch recombination.
Proc Natl Acad Sci U S A. 2010 Jan 12 ;107(2):809-14. Epub 2009 Dec 22 .

PubMed
Delivery of evidence-based treatment for multiple anxiety disorders in primary c...
Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.
JAMA. 2010 May 19 ;303(19):1921-8.

PubMed
A randomized trial comparing digital video disc with written delivery of falls p...
A randomized trial comparing digital video disc with written delivery of falls prevention education for older patients in hospital.
J Am Geriatr Soc. 2009 Aug ;57(8):1458-63. Epub 2009 Jun 8 .

PubMed
HIV-1 transmission, by stage of infection.
HIV-1 transmission, by stage of infection.
J Infect Dis. 2008 Sep 1 ;198(5):687-93.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: